Animal & Veterinary
FDA Animal Feed Safety System 2007 Public Meeting
May 22, 2007
9a.m. to 4p.m.
The Food and Drug Administration (FDA) is holding a public meeting to present work-in-progress on a method for ranking feed contaminants according to the relative risks they pose to animal and public health.
This is the 4th in a series of Animal Feed Safety System (AFSS) Public Meetings. The FDA is presenting work-in-progress on a method for ranking animal feed contaminants by their relative risks to animal and human health. The relative risk posed by feed contaminants to animal and human health consists of two components; namely, 1) Health Consequence Scoring and 2) Exposure Scoring. At this meeting the Agency will describe the methods it plans to use to develop animal and human Exposure Scoring for chemical, physical and microbiological feed contaminants.
If you have further questions regarding the subject of the meeting, contact Zoe Gill at 240-453-6867 or by email: zoe.gill@fda.hhs.gov.
Additional Information
- AFSS 2007 Agenda
- AFSS 2007 Meeting Attendees (PDF - 50KB)
- FDA Public Meeting on Animal Feed Safety System (AFSS)
CVM Update, March 29, 2007 - Notice of public meeting; request for comments: Meeting to Present Work-in-Progress on a Method for Ranking Feed Contaminants According to the Relative Risks They Pose to Animal and Public Health
Meeting Presentations
- Welcome
Dr. Daniel McChesney, Director, CVM Office of Surveillance and Compliance - Risk Assessment, the AFSS Model and Introduction to Exposure Scoring
Dr. Barry Hooberman, CVM, Office of New Animal Drug Evaluation - Swine Feed Examples
Dr. Timothy C. Schell, CVM, Office of New Animal Drug Evaluation - Initial Contaminant Levels in Swine Feed Ingredients
Dr. Karen Ekelman, CVM, Office of Surveillance and Compliance - Process Effects on Microbiological Contaminant Levels
Dr. Phares O. Okelo, CVM, Office of Surveillance and Compliance - Effect of Manufacturing Processes on Chemical Contaminants
Dr. Linda Benjamin, CVM, Office of Surveillance and Compliance - Exposure Scoring IV: Overview
Dr. Barry Hooberman, CVM, Office of New Animal Drug Evaluation

